Skip to main content
Gut logoLink to Gut
. 1977 Sep;18(9):717–720. doi: 10.1136/gut.18.9.717

Carbenoxolone sodium capsules in the treatment of duodenal ulcer. An endoscopic controlled trial.

PMCID: PMC1411639  PMID: 342359

Abstract

Eighty-six patients with duodenal ulcer were treated in a multicentre controlled trial with carbenoxolone capsules (Duogastrone, 50 mg four times a day for six weeks) or a placebo. Sixty-nine patients accepted endoscopy at the beginning and end of the treatment. Symptomatic responses and endoscopic improvement were significantly greater in those receiving the active preparation than in those receiving the control capsules, complete, endoscopically assessed, healing being achieved in 65% and 20%, respectively, of individuals having accepted endoscopy, after six weeks' treatment. Side-effects of salt and water retention or hypokalaemia were noted in over a quarter of those receiving the carbenoxolone capsules, but none of the adverse effects was severe enough to necessitate withdrawal of treatment.

Full text

PDF
717

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown P., Salmon P. R., Thien-Htut, Read A. E. Double-blind trial of carbenoxolone sodium capsules in duodenal ulcer therapy, based on endoscopic diagnosis and follow-up. Br Med J. 1972 Sep 16;3(5828):661–664. doi: 10.1136/bmj.3.5828.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cliff J. M., Milton-Thompson G. J. A double-blind trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer. Gut. 1970 Feb;11(2):167–170. doi: 10.1136/gut.11.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cocking J. B. A trial of amylopectin sulfate (SN-263) and propantheline bromide in the long term treatment of chronic duodenal ulcer. Gastroenterology. 1972 Jan;62(1):6–10. [PubMed] [Google Scholar]
  4. Craig O., Hunt T., Kimerling J. J., Parke D. V. Carbenoxolone in the treatment of duodenal ulcer. Practitioner. 1967 Jul;199(189):109–111. [PubMed] [Google Scholar]
  5. Kaye M. D., Rhodes J., Beck P., Sweetnam P. M., Davies G. T., Evans K. T. A controlled trial of glycopyrronium and l-hyoscyamine in the long-term treatment of duodenal ulcer. Gut. 1970 Jul;11(7):559–566. doi: 10.1136/gut.11.7.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Montgomery R. D., Lawrence I. H., Manton D. J., Mendl K., Rowe P. A controlled trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer. Gut. 1968 Dec;9(6):704–706. doi: 10.1136/gut.9.6.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SUN D. C. LONG-TERM ANTICHOLINERGIC THERAPY FOR PREVENTION OF RECURRENCES IN DUODENAL ULCER. Am J Dig Dis. 1964 Oct;9:706–716. doi: 10.1007/BF02237730. [DOI] [PubMed] [Google Scholar]
  8. Sun D. C., Ryan M. L. A controlled study on the use of propantheline and amylopectin sulfate (SN-263) for recurrences in duodenal ulcer. Gastroenterology. 1970 Jun;58(6):756–761. [PubMed] [Google Scholar]
  9. Trevino H., Anderson J., Davey P. G., Henley K. S. The effect of glycopyrrolate on the course of symptomatic duodenal ulcer. Am J Dig Dis. 1967 Oct;12(10):983–987. doi: 10.1007/BF02233256. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES